This is a case presentation of a HHV8-positive multicentric Castleman's disease (MCD) of plasma cell type. The patient failed to respond to combined immunosuppressive therapy and monoclonal anti-CD20 therapy. Interestingly, administration of anti-IL-6R antibody stabilized the disease and resulted in clearance of HHV8 from the involved lymph nodes.
|Translated title of the contribution||Tocilizumab treatment of HHV8-positive/HIV-negative, multricentric plasma cell type Castleman's disease|
|Number of pages||5|
|Publication status||Published - Nov 29 2016|
ASJC Scopus subject areas